Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Cooper Health System

About this trial

Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.

Eligibility criteria

Qualifiers

age>18 years

patient undergoing EBUS bronchoscopy with moderate conscious sedation.

Disqualifiers

subjects with previous nasal surgeries

subjects with oxygen saturation <90% on room air prior to procedure

subjects who are pregnant

subjects with known facial fractures or recent facial trauma

Trial design

Treatments tested in this trial

  • Vapotherm
  • Regular nasal canula

Treatment groups

198 Participants
are divided into 2 treatment groups

Sponsors and collaborators